<?xml version="1.0" encoding="UTF-8" ?><rss 
        version         = "2.0"
        xmlns:content   = "http://purl.org/rss/1.0/modules/content/"
        xmlns:wfw       = "http://wellformedweb.org/CommentAPI/"
        xmlns:dc        = "http://purl.org/dc/elements/1.1/"
        xmlns:atom      = "http://www.w3.org/2005/Atom"
        xmlns:sy        = "http://purl.org/rss/1.0/modules/syndication/"
        xmlns:slash     = "http://purl.org/rss/1.0/modules/slash/"
        type            = "0"
                >
        <channel><item post_id='108983'><title>Accord Healthcare erhält positives CHMP-Gutachten für Denosumab, Osvyrti® und Jubereq®</title><link>https://business24.ch/2025/04/02/accord-healthcare-erhaelt-positives-chmp-gutachten-fuer-denosumab-osvyrti-und-jubereq/</link><pubDate>Wed, 02 Apr 2025 12:00:02 +0000</pubDate>		<category><![CDATA[Presseportal]]></category>
		<category><![CDATA[noinjection]]></category>
<guid isPermalink='false'>https://business24.ch/?p=108983</guid><post-id xmlns="com-wordpress:feed-additions:1">108983</post-id></item></channel>
      </rss>